ASCO announces new Research on the Impact of COVID-19 on Patients With Cancer, Precision Medicine, and Access to Care to be Featured in the ASCO20 Virtual Scientific Program
View from the Willis Tower (Sears Tower, its name for 36 years)
ASCO Press Release:
ALEXANDRIA, Va. – This year the American Society of Clinical Oncology (ASCO) will deliver the latest cancer science to the global oncology community in a new virtual format. Advances in immunotherapies and targeted therapies for lung, colorectal, ovarian, and bladder cancers; improvements in access to cancer care, as well as the impact of COVID-19 on people with cancer are among the topics that will be highlighted in the ASCO20 Virtual Scientific Program’s official Press Program.
The ASCO20 Virtual Scientific Program, to be held May 29-31, will provide an engaging lineup of scheduled and on-demand scientific content across a variety of approaches, disciplines, and specialties. The theme of this year’s meeting is Unite and Conquer: Accelerating Progress Together.
Approximately 2,215 abstracts were accepted for presentation during the ASCO20 Virtual Scientific Program, and more than 3,400 additional abstracts were accepted for online publication. The vast majority of these abstracts will be publicly posted on abstracts.asco.org on Wednesday, May 13, at 5:00 p.m. ET. Late-Breaking Abstracts (LBAs), including Plenary abstracts, will be released online on Thursday, May 28, at 5:00 p.m. ET.
Oncoletter provides you with the links to all oral abstract sessions as well as links to interviews about papers presented at the ASCO20 Virtual Scientific Meeting.